Home
neovii

neovii Market Share Analysis for June 2026

Industry: N/A

Domainneovii.com

Year Founded2003

Employees51 - 200

Annual Revenue$25M - $50M

neovii

neovii (including company regionals)

neovii.com

See more website traffic and engagement information

neovii Revenue up to June 2026 is 25M - 50M

revenue generated by neovii top domains

neovii top domains revenue over 3 years

Revenue for neovii top domains

neovii.com25M - 50M

See more with Sales Intelligence

Total visits to neovii's top domains

Understand neovii market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neovii.com1.6K

See more with Sales Intelligence

Avg. visit duration in neovii's top domains

Analyze neovii engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neovii.com00:05:08

See more with Sales Intelligence

Avg. pageviews on neovii's top domains

See how neovii keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neovii.com6.72

See more with Sales Intelligence

neovii top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by neovii

These are the website technologies, by industry, used by neovii top domains

Widget (3)

Twemoji

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

Audio Video Media (1)

YouTube

More Technologies

5

See all

News & Signals from neovii

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTel Aviv University partners with Neovii Biotech GmbH.Neovii, Tel Aviv University partner for COVID-19 vaccine Israeli firm Ramot has inked a license agreement with Neovii, a Swiss-based biopharmaceutical company, for the research and development of a COVID-19...

NewsNeovii Biotech GmbH is developing novel COVID-19 vaccine on May 15th '20.Under the agreement, Neovii will collaborate with Gershoni and TAU to develop a first-in-class COVID-19 vaccine that reconstructs the coronavirus’ Receptor Binding Motif (RBM), a critical structure of its “spike” protein.

NewsNeovii Biotech GmbH is developing coronavirus vaccine.Neovii has signed a research agreement with Tel Aviv University to develop a coronavirus vaccine.